Rapamycin (Sirolimus) Compounding Legal Status: FDA Approval, Off-Label Use, and Pharmacy Rules

Print or save as PDF

Key numbers

  • 10 mgTop weekly dose of compounded rapamycin tested in the PEARL longevity trial in healthy adultsSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 48-weekLength of the PEARL trial of compounded rapamycin in healthy normative-aging adultsSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 1 mgDaily rapamycin dose in a 2018 pilot of healthy older adults, not an approved useSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Sirolimus

At a glance

  • Generic name / sirolimus (also called rapamycin)
  • Brand / Rapamune (Pfizer) [2]
  • Forms / Tablets and oral solution [2]
  • Approved uses / Kidney transplant rejection prophylaxis (age 13 and older) and LAM [2]
  • Longevity use / Off-label; no FDA-approved aging or longevity indication [2]
  • Compounded status / Not FDA-approved [1]
  • Prescription status / Prescription-only medicine [2]
  • Boxed warning / Immunosuppression; use not recommended in liver or lung transplant patients [2]

What is sirolimus approved for?

Rapamune is Pfizer's brand of sirolimus, an mTOR inhibitor immunosuppressant, available as tablets and oral solution [2]. Its FDA-approved uses are narrow: prophylaxis of organ rejection in patients aged 13 and older receiving kidney transplants, and treatment of LAM [2]. In low-to-moderate-immunologic-risk patients, it is used initially with cyclosporine and corticosteroids; the Rapamune label recommends withdrawing cyclosporine 2 to 4 months after transplant [2]. In high-immunologic-risk patients, it is used with cyclosporine and corticosteroids for the first 12 months [2]. There is no FDA-approved indication for aging, longevity or healthspan [2].

What does the boxed warning say?

The boxed warning is about immunosuppression. It says increased susceptibility to infection and the possible development of lymphoma and other malignancies, particularly of the skin, may result from immunosuppression [2]. It says only physicians experienced in immunosuppressive therapy and management of renal transplant patients should use Rapamune for kidney transplant rejection prophylaxis [2].

It also says use is not recommended in liver or lung transplant patients. In liver transplant studies, Rapamune with tacrolimus was associated with excess mortality and graft loss, and Rapamune with cyclosporine or tacrolimus was associated with hepatic artery thrombosis, mostly within 30 days [2]. In lung transplant patients, bronchial anastomotic dehiscence, most of it fatal, has been reported [2].

Is compounded sirolimus FDA-approved?

No. Compounded rapamycin is not FDA-approved [1]. A generic drug is different: it is FDA-approved and must establish therapeutic equivalence to the brand-name drug, while a compounded drug does not [1].

The FDA also says compounded drugs should be used only when an FDA-approved drug cannot meet a patient's medical needs. Unnecessary use can expose patients to serious risks, including contamination or a product with too much or too little active ingredient [1].

What federal pharmacy rules apply?

Federal law addresses compounding by licensed pharmacists in state-licensed pharmacies or federal facilities, by physicians, and by outsourcing facilities [1]. Outsourcing facilities register with the FDA, are inspected by the FDA on a risk-based schedule, and must follow current good manufacturing practice (CGMP) requirements [1]. State-licensed pharmacies that are not registered as outsourcing facilities are generally overseen day to day by state boards of pharmacy, although the FDA conducts surveillance and for-cause inspections [1].

Compounding from bulk active ingredients is restricted. The FDA's bulk drug substance page says state-licensed pharmacists and physicians may use a bulk substance only if it complies with an applicable USP or NF monograph, is a component of an FDA-approved drug product when no monograph exists, or appears on the FDA's list of bulk substances that can be used in compounding. Outsourcing facilities have separate limits [3]. The FDA says it is still developing those lists [3].

Questions worth asking

Choose the questions you want to keep

Is rapamycin for longevity off-label?

Yes. Longevity and anti-aging use falls outside the label's two approved indications [2]. The PEARL trial used compounded rapamycin, not an FDA-approved sirolimus product [4].

PEARL was a 48-week decentralized, double-blind, placebo-controlled trial in healthy, normative-aging adults. Participants received placebo or 5 mg or 10 mg compounded rapamycin once weekly [4]. The primary outcome, visceral adiposity measured by DXA, did not change significantly (p=0.942) [4]. Adverse and serious adverse events were similar across groups, and blood biomarkers stayed within normal ranges [4]. Lean tissue mass and self-reported pain improved significantly in women on 10 mg; emotional well-being and general health improved significantly on 5 mg [4]. The authors concluded that low-dose intermittent rapamycin was relatively safe over 48 weeks, but efficacy was not established [4]. PEARL measured healthspan metrics, not lifespan [4].

A smaller 2018 pilot randomized 25 generally healthy adults aged 70 to 95 to 1 mg rapamycin daily or placebo. Eleven rapamycin and 14 placebo participants completed at least 8 weeks [5]. Reported side effects in the rapamycin group were facial rash in one participant, stomatitis in one and gastrointestinal issues in two [5]. The rapamycin group had statistically significant decreases in hemoglobin, hematocrit, red cell count, RDW, MCV and MCH, and the study had no clinical benefit endpoint for longevity [5].

Mouse data are not human regulatory evidence. In a 2009 study, rapamycin fed to mice beginning at 600 days of age increased lifespan at the age of 90% mortality by 14% in females and 9% in males [6].

What people on Reddit report

Reddit users in one thread describing how they got rapamycin prescriptions for longevity, and whether that route is legal.

ActiveTemporary1870 · Rapamycin

It is NOT illegal ; it is what the FDA calls ''off label'' since they don't consider longevity as a medical condition...But you do need an RX .

Says longevity use is legal because it is off-label, but a prescription is still required.

Read the source discussion

Man-o-Trails · Rapamycin

There are several MD's in the US prescribing Rapa for longevity, but they are only licensed in a few states. In most cases, that means you have to fly out to visit them, and get your prescription filled in the same state. The pharmacy can FedEx to you legally.

Says prescribers are licensed only in some states, so patients may need to travel, and that the pharmacy can ship the medicine.

Read the source discussion

RaspberryExcellent56 · Rapamycin

If you get a script you can have a compounding pharmacy fill the prescription and mail it to you.

Says a compounding pharmacy can fill a prescription and mail it to the patient.

Read the source discussion

Does the Rapamune label cover compounded rapamycin?

No. The Rapamune label covers the brand's tablets and oral solution [2]. It is not a label for a compounded sirolimus product. The label's warnings and interaction rules describe Rapamune. For example, the label says sirolimus is a substrate of CYP3A4 and P-gp, lists strong inducers and inhibitors to avoid, and says grapefruit juice must not be taken with Rapamune or used to dilute it [2].

Is Rapamune approved outside the United States?

The European Medicines Agency lists Rapamune as authorized in the European Union for preventing kidney transplant rejection in adults at low-to-moderate risk and for sporadic LAM [7]. The EMA's dosing is 6 mg as a first dose then 2 mg once daily for transplant, and 2 mg daily for S-LAM [7].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, what must a generic drug establish that a compounded drug does not?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Frequently asked questions

Is compounded rapamycin FDA-approved?
No. Compounded rapamycin is not FDA-approved [1]. Sirolimus is prescription-only [2].
What is rapamycin approved for?
The Rapamune label approves sirolimus for kidney transplant rejection prophylaxis in patients 13 and older and for LAM [2]. Aging and longevity are not FDA-approved indications [2].
Can sirolimus be legally compounded?
Federal law addresses compounding by licensed pharmacists, physicians and registered outsourcing facilities, with different quality standards [1]. A compounded sirolimus product is still not FDA-approved [1].
Is low-dose rapamycin for longevity off-label?
Yes. Longevity use is outside the label's approved indications [2]. The PEARL trial used 5 mg or 10 mg compounded rapamycin once weekly for 48 weeks; adverse events were similar to placebo, but efficacy was not established [4].
Does the Rapamune label cover compounded rapamycin?
No. The label covers Rapamune tablets and oral solution [2].
What warning does the Rapamune label carry?
The boxed warning covers immunosuppression, increased infection risk and possible lymphoma, and says use is not recommended in liver or lung transplant patients [2].

References

Show all 8 referencesHide references
  1. Compounding and the FDA: Questions and Answers | FDA.
  2. U.S. National Library of Medicine, DailyMed. Rapamune sirolimus tablets and oral solution (Pfizer) prescribing information. Rapamune sirolimus tablets and oral solution (Pfizer) label
  3. Bulk Drug Substances Used in Compounding | FDA.
  4. Moel M, Harinath G, Lee V, Nyquist A, Morgan SL, Isman A, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY). 2025;17(4):908-936.
  5. Kraig E, Linehan LA, Liang H, Romo TQ, Liu Q, Wu Y, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol. 2018;105:53-69.
  6. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-5.
  7. Rapamune | European Medicines Agency (EMA).
  8. Reddit participants. Legal Source? (r/Rapamycin). Accessed 2026-11-11.
Evidence overview for Rapamycin (Sirolimus) Compounding Legal Status: FDA Approval, Off-Label Use, and Pharmacy Rules